- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/66 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 317/66
Total number of patents in this class: 94
10-year publication summary
|
18
|
11
|
9
|
9
|
2
|
5
|
3
|
11
|
7
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The University of Sydney | 598 |
5 |
| Bristol-myers Squibb Company | 4884 |
4 |
| Adeka Corporation | 1363 |
4 |
| Nihon Nohyaku Co., Ltd. | 326 |
4 |
| The Regents of the University of California | 19943 |
3 |
| The Scripps Research Institute | 1350 |
3 |
| SK Biopharmaceuticals Co., Ltd. | 261 |
3 |
| Elanco Tiergesundheit AG | 415 |
3 |
| BASF SE | 20915 |
2 |
| Duke University | 3067 |
2 |
| Council of Scientific & Industrial Research | 1426 |
2 |
| Flexus Biosciences, Inc. | 13 |
2 |
| The Florida International University Board of Trustees | 622 |
2 |
| Metabasis Therapeutics, Inc. | 40 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2856 |
2 |
| The University of British Columbia | 1502 |
2 |
| Firmenich Incorporated | 147 |
2 |
| F. Hoffmann-La Roche AG | 7920 |
1 |
| Abbott Laboratories | 2405 |
1 |
| BASF Corporation | 1715 |
1 |
| Other owners | 44 |